Prostaglandins, especially PGE2 and PGI2, protect the gastric mucosa. They help support the normal defence mechanisms by maintaining submucosal blood flow, stimulating bicarbonate secretion, and enhancing gastric mucus production.
I
Non-steroidal anti-inflammatory drugs (NSAIDs) cause irritation, ulceration, and bleeding in the stomach,2 predominantly, it is believed, by inhibiting endogenous prostaglandin synthesis. Misoprostil, a PGE1 analogue, will effectively prevent NSAID damage to the gastric mucosa. 3 In the oesophagus the converse is true, NSAIDs protect and prostaglandins are harmful. Several independent studies have shown that NSAIDs such as indomethacin are effective in preventing and reversing established oesophageal mucosal inflammation. This effect has been described in the cat,4-7 opossum,"-'0 monkey," man,'2 13 rabbit,'415 and mouse '6 where the oesophagus has been exposed to insult in the form of acid,474 radiation, 8 12 16 or proteolytic digestion.'5 These studies show a twin beneficial effect of NSAIDs in the oesophagus -there is an initial enhancement of tissue resistance to noxious stimuli followed by an anti-inflammatory effect. These observations can be explained biochemically.
Healthy oesophageal mucosa of the rabbit17""9 and man20 metabolise arachidonic acid predominantly via the 12- lipoxygenase pathway (Figure) to form the leukotriene 12 
